Ellis Investment Partners LLC Has $1.59 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Ellis Investment Partners LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 12.8% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,115 shares of the healthcare conglomerate’s stock after purchasing an additional 353 shares during the quarter. Ellis Investment Partners LLC’s holdings in UnitedHealth Group were worth $1,586,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently bought and sold shares of UNH. Arlington Trust Co LLC lifted its stake in shares of UnitedHealth Group by 3.3% during the second quarter. Arlington Trust Co LLC now owns 1,810 shares of the healthcare conglomerate’s stock valued at $922,000 after acquiring an additional 57 shares during the period. Caprock Group LLC lifted its stake in shares of UnitedHealth Group by 48.4% during the second quarter. Caprock Group LLC now owns 21,006 shares of the healthcare conglomerate’s stock valued at $10,698,000 after acquiring an additional 6,848 shares during the period. Counterweight Ventures LLC lifted its stake in shares of UnitedHealth Group by 1.6% during the second quarter. Counterweight Ventures LLC now owns 4,808 shares of the healthcare conglomerate’s stock valued at $2,449,000 after acquiring an additional 74 shares during the period. Napean Trading & Investment Co Singapore PTE Ltd lifted its stake in shares of UnitedHealth Group by 7.4% during the second quarter. Napean Trading & Investment Co Singapore PTE Ltd now owns 40,163 shares of the healthcare conglomerate’s stock valued at $20,453,000 after acquiring an additional 2,767 shares during the period. Finally, Acadian Asset Management LLC lifted its stake in shares of UnitedHealth Group by 17.5% during the second quarter. Acadian Asset Management LLC now owns 81,483 shares of the healthcare conglomerate’s stock valued at $41,490,000 after acquiring an additional 12,145 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. JPMorgan Chase & Co. increased their target price on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. HSBC increased their target price on UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Morgan Stanley increased their target price on UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Truist Financial increased their target price on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Finally, Argus increased their price target on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $614.17.

Insider Activity

In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Up 0.2 %

NYSE:UNH opened at $596.88 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. The stock has a 50-day simple moving average of $558.98 and a 200 day simple moving average of $515.11. The company has a market cap of $549.36 billion, a PE ratio of 36.48, a PEG ratio of 1.68 and a beta of 0.58. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $607.94.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. The firm had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business’s revenue was up 6.4% compared to the same quarter last year. During the same period last year, the company earned $6.14 earnings per share. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be paid a $2.10 dividend. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.41%. UnitedHealth Group’s dividend payout ratio is 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.